April Lace Redmon, in Arvada, CO - Specialist

April Lace Redmon, is a Specialist based in Arvada, Colorado. April Lace Redmon is licensed to practice in Texas (license number 114359) and her current practice location is 6447 Quail St, Arvada, Colorado. She can be reached at her office (for appointments etc.) via phone at (720) 864-1101.

NPI number for April Lace Redmon is 1386004935 and her current mailing address is 2600 W 103rd Ave Apt 715, Federal Heights, Colorado. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1386004935.

Contact Information

	April Lace Redmon,
	6447 Quail St, Arvada, CO 80004-2600
	(720) 864-1101
	Not Available

Healthcare Provider's Profile

Full Name	April Lace Redmon
Gender	Female
Speciality	Specialist
Location	6447 Quail St, Arvada, Colorado
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1386004935
Provider Enumeration Date: 02/24/2016
Last Update Date: 03/14/2024

Medical Identifiers

Medical identifiers for April Lace Redmon such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1386004935	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	OT.0007977 (Colorado)	Secondary
174400000X	Specialist	114359 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. April Lace Redmon is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
April Lace Redmon, 2600 W 103rd Ave Apt 715, Federal Heights, CO 80260-6194 Ph: (817) 733-4735	April Lace Redmon, 6447 Quail St, Arvada, CO 80004-2600 Ph: (720) 864-1101

News Archive

Expert scientific panel offers recommendations for monitoring adverse events related to dietary supplements

Protecting the health of those that consume dietary supplements is of great importance to public health agencies like the Food and Drug Administration (FDA) and the product manufacturers.

Human brain may be more adept at distinguishing smells than previously thought

Brains are able to adjust automatically to the demands of distinguishing between small differences in smell, new research at the University of Chicago shows.

Minimally-invasive deep aging clocks could improve response to COVID-19 vaccine

Deep Longevity, a fully-owned subsidiary of Regent Pacific (SEHK:0575.HK), specializing in the development and the application of next-generation artificial intelligence (AI) for aging and longevity research, today announced the publication of an article in Lancet Healthy Longevity titled "The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19".

CureDM receives patent allowance for novel islet neogenesis program

CureDM, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application covering a Human proIslet Peptide (HIP) and methods related to its use and administration for treating type 1 diabetes.

Patients with suspicious axillary lymph nodes in their breasts should first undergo ultrasound-guided fine-needle aspiration to avoid unnecessary surgery

Currently, breast cancer patients undergo axillary lymph node dissection for accurate staging and control of the cancer. In many cases, this major procedure can be replaced by sentinel lymph node biopsy, which is a more simple and less invasive surgical procedure, but many still have to undergo axillary dissection after the sentinel lymph node biopsy.

April Lace Redmon, - in Arvada, CO